Stockholm3 - A new option to detect Prostate Cancer
Prostate cancer is the second most often diagnosed cancer and the sixth most prevalent cause of cancer mortality in males globally.1 It is usually screened by measuring prostate specific antigen (PSA) levels in the blood. However, the PSA test results in unnecessary biopsies, over-diagnosis, over-t...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Pakistan Medical Association
2022-04-01
|
Series: | Journal of the Pakistan Medical Association |
Online Access: | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/5109 |
_version_ | 1797820886150021120 |
---|---|
author | Moosa Zulfiqar Ali Roshaan Ahmad Amna Akmal |
author_facet | Moosa Zulfiqar Ali Roshaan Ahmad Amna Akmal |
author_sort | Moosa Zulfiqar Ali |
collection | DOAJ |
description |
Prostate cancer is the second most often diagnosed cancer and the sixth most prevalent cause of cancer mortality in males globally.1 It is usually screened by measuring prostate specific antigen (PSA) levels in the blood. However, the PSA test results in unnecessary biopsies, over-diagnosis, over-treatment, and higher expenses.2 The Karolinska Institutet in Stockholm, Sweden, developed the Stockholm3 test to overcome PSA test’s shortcomings.
---Continue
|
first_indexed | 2024-03-13T09:44:50Z |
format | Article |
id | doaj.art-c523b63953ea4bc3811f081ede78f8df |
institution | Directory Open Access Journal |
issn | 0030-9982 |
language | English |
last_indexed | 2024-03-13T09:44:50Z |
publishDate | 2022-04-01 |
publisher | Pakistan Medical Association |
record_format | Article |
series | Journal of the Pakistan Medical Association |
spelling | doaj.art-c523b63953ea4bc3811f081ede78f8df2023-05-25T04:22:17ZengPakistan Medical AssociationJournal of the Pakistan Medical Association0030-99822022-04-0172410.47391/JPMA.5109Stockholm3 - A new option to detect Prostate CancerMoosa Zulfiqar Ali0Roshaan Ahmad1Amna Akmal2Medical College, Combined Military Hospital, Lahore, PakistanMedical College, Combined Military Hospital, Lahore, Pakistan Medical College, Combined Military Hospital, Lahore, Pakistan Prostate cancer is the second most often diagnosed cancer and the sixth most prevalent cause of cancer mortality in males globally.1 It is usually screened by measuring prostate specific antigen (PSA) levels in the blood. However, the PSA test results in unnecessary biopsies, over-diagnosis, over-treatment, and higher expenses.2 The Karolinska Institutet in Stockholm, Sweden, developed the Stockholm3 test to overcome PSA test’s shortcomings. ---Continue https://www.ojs.jpma.org.pk/index.php/public_html/article/view/5109 |
spellingShingle | Moosa Zulfiqar Ali Roshaan Ahmad Amna Akmal Stockholm3 - A new option to detect Prostate Cancer Journal of the Pakistan Medical Association |
title | Stockholm3 - A new option to detect Prostate Cancer |
title_full | Stockholm3 - A new option to detect Prostate Cancer |
title_fullStr | Stockholm3 - A new option to detect Prostate Cancer |
title_full_unstemmed | Stockholm3 - A new option to detect Prostate Cancer |
title_short | Stockholm3 - A new option to detect Prostate Cancer |
title_sort | stockholm3 a new option to detect prostate cancer |
url | https://www.ojs.jpma.org.pk/index.php/public_html/article/view/5109 |
work_keys_str_mv | AT moosazulfiqarali stockholm3anewoptiontodetectprostatecancer AT roshaanahmad stockholm3anewoptiontodetectprostatecancer AT amnaakmal stockholm3anewoptiontodetectprostatecancer |